pocketful logo
Kopran Ltd logo

Kopran Ltd

NSE: KOPRAN BSE: 524280

₹131.83

(-1.18%)

Mon, 02 Mar 2026, 03:20 pm

mtf coin illustrationMTF 5x

Kopran Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    634.96

  • Net Profit

    38.55

  • P/B

    1.63

  • Sector P/E

    32.50

  • P/E

    21.94

  • EV/EBITDA

    12.58

  • Debt/Equity (Industry)

    0.23

  • Interest Cover (Industry)

    10.03

  • ROCE (Industry)

    12.82

  • RONW (Industry)

    12.23

  • ROE

    7.64

  • ROCE

    9.60

  • Debt/Equity

    0.24

  • EPS (TTM)

    3.43

  • Dividend Yield

    2.28

  • Book Value

    103.77

  • Interest Cover

    6.56

Analysis

all

thumbs up icon

Pros

  • Kopran is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Kopran is profitable, therefore cash runway is not a concern.
  • Kopran is profitable, therefore cash runway is not a concern.
  • Debt is well covered by operating cash flow (39.4%, greater than 20% of total debt).
  • Debt is covered by short term assets, assets are 2.4x debt.
thumbs up icon

Cons

  • Unable to evaluate Kopran's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Kopran's dividend against the top 25% market benchmark as the company has not reported any payouts.
  • Kopran's level of debt (49%) compared to net worth is high (greater than 40%).
  • High level of physical assets or inventory.
  • The average tenure for the Kopran board of directors is less than 3 years, this suggests a new board.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters44.4244.4244.4244.4244.46
FII0.360.600.761.120.86
DII0.000.000.000.000.00
Public55.2254.9854.8254.4554.68
Government00000

Read More

Technical Analysis

RSI

38.38

MACD

-2.26

50 DMA

138.84

200 DMA

160.57

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic186.86159.84145.84132.82118.82105.8078.78
Fibonacci159.84149.52143.14132.82122.50116.12105.80
Camarilla139.26136.78134.31132.82129.35126.88124.40

Pivots Level: Classic

R3

+54.04

186.86

R2

+27.02

159.84

R1

+13.01

145.84

132.82
132.82
Pivot Point
LTP: 126.66

S1

-14.01

118.82

S2

-27.02

105.80

S3

-54.04

78.78

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    131.13

  • 20-EMA

    132.91

  • 30-EMA

    134.35

  • 50-EMA

    137.08

  • 100-EMA

    144.47

  • 200-EMA

    159.36

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
22 Jan 2026board-meetingsQuarterly Results
12 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
04 Aug 2025dividendFinal Dividend - Rs. - 304 Sept 2025
29 Jul 2025agm
15 May 2025dividend₹3.00 Dividend /Share04 Sept 2025
19 Aug 2024agm
02 Aug 2024dividendAnnual General Meeting/Dividend - Rs 3 Per Share03 Sept 2024
16 May 2024dividend₹3.00 Dividend /Share03 Sept 2024
17 Aug 2023agm
07 Aug 2023dividendAnnual General Meeting/Dividend - Rs 3 Per Share08 Sept 2023

Read More

Peer Comparison

Kopran Ltd logo

Kopran Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Kopran Ltd About

Kopran is engaged in the business of manufacturing of Formulation (Finished Dosage Form).

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1958

Headquarters

CEO

Susheel G Somani

Employees

Contact

Website icon

Website

http://www.kopran.com

Email icon

Email

sunil@kopran.com

Phone icon

Phone

91-22-43661111

Location icon

Location

Parijat House 1076, Dr E Moses Road Worli, Mumbai, Maharashtra, 400018

Read More

Kopran Ltd Company History

YearHistory
2005
  • The Company appointed Mr.H.P.Vyas as Company Secretary
  • The Company entered into a Strategic Alliance with Merck Specialities Pvt Ltd
2006
  • The company signed a distribution pact with Mumbai-based Manish Pharma for its complete range of over the counter (OTC) products
2011
  • The company appointed Mr. Abhinav Mathur as a Company Secretary & Compliance Officer
2013
  • Kopran Ltd. launched a new brand SPARKLE in the FMCG category
2018
  • Kopran Research Laboratories Limited, a wholly owned subsidiary of the Company purchased API facility at Panoli, Gujarat

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
HRTI PRIVATE LIMITEDSell256605154.6130 Dec 2025
HRTI PRIVATE LIMITEDBuy272129154.5830 Dec 2025
NK SECURITIES RESEARCH PRIVATE LIMITEDSell367990151.523 Dec 2025
SILVERLEAF CAPITAL SERVICES PRIVATE LIMITEDBuy500612152.0423 Dec 2025
SILVERLEAF CAPITAL SERVICES PRIVATE LIMITEDSell500612152.1623 Dec 2025
NK SECURITIES RESEARCH PRIVATE LIMITEDBuy367990151.3823 Dec 2025
VIRAJ RUSSELL MEHTASell400000179.623 Jun 2025
VANDANA SURENDRA SOMANIBuy317500174.1319 Mar 2025
G CLARIDGE &COMANY LTDSell317500174.1319 Mar 2025
BOFA SECURITIES EUROPE SABuy251971348.6513 Sept 2024

Read More

Kopran Ltd News

Kopran Gets BSE Nod for Merger with No Adverse Remarks

Kopran Limited receives BSE observation letter with no adverse observations for proposed merger scheme with Kopran Laboratories Limited, moving closer to regulatory approval.

27 Feb 2026

co actions results

Kopran Q3 EBITDA Drops 10% YoY to ₹178M

Kopran reported Q3 EBITDA of ₹178 million, down from ₹198 million year-over-year, with EBITDA margin declining to 9.14% from 11.93% in the same period last year.

22 Jan 2026

co actions results

Kopran Faces GST Authority Search at Facilities

Maharashtra GST authorities initiated search operations at Kopran Limited's Mumbai office and Khopoli facility on January 21, 2026, under Section 67 of state GST Act. Company cooperating fully.

21 Jan 2026

stocks

Kopran Board Meeting Set for January 22, 2026

Kopran Limited has scheduled a board meeting on January 22, 2026, to consider and approve unaudited standalone and consolidated financial results for Q3FY26 ended December 31, 2025.

13 Jan 2026

co actions results

Kopran Limited Gets CRISIL Rating Reaffirmation

CRISIL reaffirms credit ratings for Kopran Limited and subsidiary with BBB+/watch developing for long-term and A2/watch developing for short-term facilities till March 31, 2026.

01 Jan 2026

stocks

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Stocks:

AllABCDEFGHIJKLMNOPQRSTUVWXYZ

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Others:

NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800